Finance

Lists
Why is VTRS down 2,21%?
Dive Deeper
VTRS:NASDAQ
Viatris Inc
US$17,72
-2,21%
(-0,40) 1D
US$17,80
+0,45% (+0,080)
After hours
Closed: 30 ກ.ຍ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTRS...
Open
US$18,16
High
US$18,17
Low
US$17,71
Mkt. cap
20,35 ຕື້
Avg. vol.
8,24 ລ້ານ
Volume
11,81 ລ້ານ
Dividend
2,71%
Quarterly dividend
US$0,12
Ex-dividend date
21 ສ.ຫ. 2026
52-wk high
US$18,43
52-wk low
US$9,69
EPS
US$-0,36
Beta
0,89
Shares outstanding
1,15 ຕື້
No. of employees
30 ພັນ
Open
US$18,16
High
US$18,17
Low
US$17,71
Mkt. cap
20,35 ຕື້
Avg. vol.
8,24 ລ້ານ
Volume
11,81 ລ້ານ
Dividend
2,71%
Quarterly dividend
US$0,12
Ex-dividend date
21 ສ.ຫ. 2026
52-wk high
US$18,43
52-wk low
US$9,69
EPS
US$-0,36
Beta
0,89
Shares outstanding
1,15 ຕື້
No. of employees
30 ພັນ
Profile
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. In 2026, Viatris ranked 100 on Time Magazine's World's Most Impactful Companies. Wikipedia
About Viatris Inc
CEOScott A. Smith
Employees30 ພັນ
Founded16 ພ.ຈ. 2020
HeadquartersCanonsburg, ເພນຊີນວາເນຍ, ສະຫະລັດ
SectorPharmaceutical industry
Analyst ratings
Based on 9 analysts giving stock ratings to VTRS in the past 3 months
Buy
Buy
5
Hold
3
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for VTRS in the last 3 months.
Highest
Current US$17,72
US$25,00 (+41,08%)
Average
US$19,44 (+9,71%)
Lowest
US$13,00 (-26,64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Les Sulewski
Oppenheimer
Buy
Initiated
US$25,00
+41,1%
09/23/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
US$25,00
+41,1%
09/23/2026
David Amsellem
Piper Sandler
Hold
Reiterated
US$13,00
-26,6%
09/16/2026
Daniel Clark
Leerink Partners
Buy
Initiated
US$20,00
+12,9%
09/09/2026
Jasper Hellweg
Argus Research
Buy
Maintained
US$20,00
+12,9%
09/08/2026
Glen Santangelo
Barclays
Buy
Reiterated
US$22,00
+24,2%
08/17/2026
Chris Schott
J.P. Morgan
Hold
Maintained
US$18,00
+1,6%
08/10/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
US$20,00
+12,9%
08/06/2026
Ashwani Verma
UBS
Buy
Maintained
US$23,00
+29,8%
08/07/2026
Jason Gerberry
Bank of America Securities
Sell
Reiterated
US$14,00
-21%
07/10/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$17,00
-4,1%
03/20/2026
Last report
6 ສ.ຫ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$0,69 / US$0,60
+15,04%beat
Revenue / Est. (USD)
3,76 ຕື້ / 3,67 ຕື້
+2,36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
3,76 ຕື້
3,70 ຕື້
3,52 ຕື້
3,76 ຕື້
Cost of goods sold
2,26 ຕື້
2,21 ຕື້
2,14 ຕື້
2,19 ຕື້
Cost of revenue
2,26 ຕື້
2,21 ຕື້
2,14 ຕື້
2,19 ຕື້
Research and development expenses
244,80 ລ້ານ
271,20 ລ້ານ
245,80 ລ້ານ
245,20 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
848,50 ລ້ານ
933,40 ລ້ານ
893,40 ລ້ານ
855,00 ລ້ານ
Operating expense
1,09 ຕື້
1,20 ຕື້
1,14 ຕື້
1,10 ຕື້
Total operating expenses
3,36 ຕື້
3,42 ຕື້
3,28 ຕື້
3,29 ຕື້
Operating income
404,60 ລ້ານ
288,20 ລ້ານ
238,60 ລ້ານ
471,50 ລ້ານ
Other non operating income
-135,90 ລ້ານ
44,90 ລ້ານ
-1,80 ລ້ານ
14,40 ລ້ານ
EBT including unusual items
-7,90 ລ້ານ
-343,00 ລ້ານ
-247,30 ລ້ານ
-64,00 ລ້ານ
EBT excluding unusual items
318,70 ລ້ານ
188,00 ລ້ານ
146,20 ລ້ານ
365,40 ລ້ານ
Income tax expense
120,30 ລ້ານ
-2,90 ລ້ານ
-423,70 ລ້ານ
54,80 ລ້ານ
Effective tax rate
-1.522,78%
0,85%
171,33%
-85,62%
Other operating expenses
-
-
-
-
Net income
-128,20 ລ້ານ
-340,10 ລ້ານ
176,40 ລ້ານ
-118,80 ລ້ານ
Net profit margin
-3,41%
-9,18%
5,02%
-3,16%
Earnings per share
0,67
0,57
0,59
0,69
Interest and investment income
-
-
-
-
Interest expense
-119,60 ລ້ານ
-119,60 ລ້ານ
-120,10 ລ້ານ
-120,70 ລ້ານ
Net interest expenses
-119,60 ລ້ານ
-119,60 ລ້ານ
-120,10 ລ້ານ
-120,70 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,09 ຕື້
981,10 ລ້ານ
914,70 ລ້ານ
1,14 ຕື້
Gain or loss from assets sale
-1,60 ລ້ານ
21,90 ລ້ານ
13,90 ລ້ານ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google